I work with clients to develop and maintain their patent portfolios in the pharmaceutical, chemical, and clean energy industries.
Tatiana is a patent attorney with over 15 years of academic and industrial research experience in pharmaceutical, chemical, and energy industries. She helps her clients protect and leverage their intellectual property assets by preparing and prosecuting U.S. and foreign patent applications, conducting due diligence, patentability, and freedom-to-operate analyses, and performing competitive intelligence and market research.
Tatiana’s background in medicinal chemistry stems from work at the Center for the Development of Therapeutics at the Broad Institute of MIT and Harvard, where she was a member of the NIH MLPCN initiative. During her Ph.D. research in Professor Richard R. Schrock’s group at MIT and postdoctoral research at Boston College under the guidance of Professor Amir H. Hoveyda she designed catalysts for asymmetric synthesis of small molecules. Tatiana also has industrial research experience in developing materials for catalytic and polymer applications, such as catalysts for automotive industry, catalysts for oil refinery processes, and polymeric materials for gas separation membranes.
Massachusetts Institute of Technology (MIT), Ph.D., Chemistry, 2007
St. Petersburg State University (Russia), B.S., Chemistry, 2002
Bar and Court Admissions
BAR ADMISSIONS
U.S. Patent & Trademark Office (Agency)
Massachusetts
Languages
Russian
Experience
Patent prosecution counsel for companies and research universities in the following areas
pharmaceutical development, methods of treatment, formulations, salt and crystal forms, prodrugs, combination therapies, drug delivery technology
nutraceuticals
cannabis
industrial processes for production of chemicals
polymer development and applications in areas from drug delivery to electronics
materials for solar and fuel cells, batteries, and methods/processes for their production, purification, and optimization
Other Publications
Headrick, T. et al., “Exo-selective, Reductive Heck Derived Polynorbornenes with Enhanced Molecular Weights, Yields, and Hydrocarbon Gas Transport Properties,” ACS Macro Lett., 2020, 9, 1363.
Pilyugina* T. S. et al., “Development of second generation thiol isomerase inhibitors to prevent thrombus formation.” Blood, 2013, 122, 926.
Pilyugina, T. S. et al., “Simple organic molecules as catalysts for enantioselective synthesis of amines and alcohols,” Nature, 2012, 494, 216.
Pilyugina, T. S., et al., “New Enantiomerically Pure Alkylimido Mo-Based Complexes. Synthesis, characterization, and activity as chiral olefin metathesis catalysts,” Organometallics, 2007, 26, 831.
We use cookies to enhance user experience, improve functionality and performance, and for analysis of website traffic. By clicking “accept”, you agree to the use of cookies. For more information about our cookie policy and the information we collect, please review our Privacy Statement.
Foley Hoag
Email Disclaimer
Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK," you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you.
If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Foley Hoag.
